Why the study?
STEMI patients without standard modifiable cardiovascular risk factors experience worse in-hospital outcomes, but the role of coronary microvascular dysfunction remains unclear.
Does coronary microvascular dysfunction mediate the association between SMuRF-less status and in-hospital MACE in STEMI patients?
Does coronary microvascular dysfunction mediate the association between SMuRF-less status and in-hospital MACE in STEMI patients?
Elevated post-procedural caIMR (a surrogate for coronary microvascular dysfunction) independently predicts in-hospital MACE and partially mediates the worse outcomes seen in STEMI patients without standard modifiable risk factors.
Answers are grounded in this paper and cite their sources.
Does not support routine caIMR-guided therapy in SMuRF-less STEMI; hypothesis-generating for microvascular mechanisms pending prospective trials.
Background: Recent studies have demonstrated that patients with ST-segment elevation myocardial infarction (STEMI) without standard modifiable cardiovascular risk factors (SMuRF-less) experience worse in-hospital outcomes than those with standard modifiable cardiovascular risk factors (SMuRFs); however, the role of a critical pathological mechanism coronary microvascular dysfunction (CMVD) in this context remains unclear. Objectives: To investigate whether CMVD mediates the association between SMuRF-less status and in-hospital major adverse cardiovascular events (MACE). Methods: = 221). In-hospital MACE and post-procedural coronary angiography-derived index of microcirculatory resistance (caIMR) were compared between groups. Mediation analysis was performed to assess the mediating effect of post-procedural caIMR on the association between SMuRF-less status and in-hospital outcomes. Results: = 0.284, 95% bootstrap CI: 0.101-0.498). Conclusion: Elevated post-procedural caIMR, as a quantitative surrogate of CMVD, independently predicted in-hospital MACE and partially mediated the association between SMuRF-less status and adverse in-hospital outcomes in STEMI patients.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: